The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
with vivance even though vivance is damphetamine it's fairly potent not as impotent as meth but fairly potent at increasing dopamine and norepinephrine it's a long extended release in dopamine and norepinephrine which reduces its overall abuse potential because it doesn't tend to create that immediate Euphoria and high and then crash below Baseline
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Vivant seems to be associated with fewer psychotic episodes and less abuse and addictive potential overall
amphetamine is a strong dopamine and norepinephrine reuptake blocker so it prevents what's already been released from being taken back up so more is available longer